Azkka Pharmaceuticals Pvt Ltd
Glimepiride (0.5mg) + Metformin (500mg)
Fpgli M 0.5 Tablet PR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet PR
Fpgli M 0.5 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Use it as advised by your doctor or check the label for directions before use. Fpgli M 0.5 Tablet PR is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Fpgli M 0.5 Tablet PR.
Fpgli M 0.5 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Fpgli M 0.5 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Fpgli M 0.5 Tablet PR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
You should continue to exercise regularly eat a healthy diet and take your other diabetes medicines along with Fpgli M 0.5 Tablet PR. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Keep this medicine in its original container or pack, tightly closed. Store it according to the instructions on the label or pack. Do not give this medication to pets, children, or others.
Yes, using Fpgli M 0.5 Tablet PR can increase the risk of lactic acidosis. This is a rare side effect that occurs when there is an excess buildup of lactic acid in the bloodstream. It can be life-threatening and requires immediate medical attention.
Fpgli M 0.5 Tablet PR combines two medications: Glimepiride and Metformin, which are used to treat type 2 diabetes mellitus (DM). Glimepiride helps lower blood sugar levels by stimulating the pancreas to release more insulin, while Metformin targets the liver to reduce glucose production and improve insulin sensitivity. This combination is not intended for treating type 1 DM.
Common side effects of Fpgli M 0.5 Tablet PR include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. It can also cause serious but rare side effects like lactic acidosis.
Yes, long-term use of Fpgli M 0.5 Tablet PR can result in Vitamin B12 deficiency due to its effect on vitamin absorption in the stomach. If left untreated, this can lead to anemia and nerve problems such as tingling sensation, numbness in hands and feet, weakness, urinary problems, changes in mental status, and difficulty maintaining balance (ataxia). It's essential to ensure adequate Vitamin B12 intake through external sources at least once a year.
Yes, Fpgli M 0.5 Tablet PR can increase the risk of hypoglycemia (low blood sugar level). Common symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. These effects are often caused by missed meals, alcohol consumption, excessive exercise, or taking other antidiabetic medications concurrently.
No, taking alcohol with Fpgli M 0.5 Tablet PR is not recommended as it can lower blood sugar levels and potentially increase the risk of hypoglycemia. It can also heighten the likelihood of lactic acidosis.